Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trial

por Patil, Vijay M., Menon, Nandini, Chatterjee, Abhishek, Tonse, Raees, Choudhari, Amit, Mahajan, Abhishek, Puranik, Ameya D., Epari, Sridhar, Jadhav, Monica, Pathak, Shruti, Peelay, Zoya, Walavalkar, Rutuja, Muthuluri, Hemanth K., Ravi Krishna, Madala, Chandrasekharan, Arun, Pande, Nikhil, Gupta, Tejpal, Banavali, Shripad, Jalali, Rakesh
Publicado 2022